ანოტაცია
Parkinson disease has potential non-motor diagnosis factors beyond the primary motor symptoms (such as bradykinesia, rigidity, or resting tremor) that are easy to overlook. Many patients also experience non-motor symptoms, which can show up years before the motor manifestations. Some of the symptoms that occur in the "non-motor" category associated with PD are skin-related symptoms. Research suggests that up to 98.6% of people with Parkinson’s report some form of skin manifestation. These signs might not just be side effects but instead, could be early clues. This objective of this review is to explore whether certain common skin conditions in PD, like seborrheic dermatitis and melanoma, could help us with determining the diagnosis of an underlying undetected Parkinson's disease sooner, by utilizing simple non- invasive applications.
წყაროები
Ernst C, Sharma A, El Haj M, Loeb GE, Jahanshahi M, Krack P. Skin disorders in
Parkinson’s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87–92. doi:10.2147/CCID.S1303192. Tagliafierro L, Chiba-Falek O. Upstream targets of α-synuclein as therapeutic targets for Parkinson’s disease. Mov Disord Clin Pract. 2016;3(4):364–372. doi:10.1002/mdc3.12425
Ravn AH, Thyssen JP, Egeberg A. Skin disorders in Parkinson’s disease: potential
biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87–92.
Buhmann C, Kassubek J, Jost WH. Skin and Parkinson’s disease: More than just
seborrheic dermatitis. J Neural Transm. 2017;124(3):277–81.
Arsenijević VA, Milobratović D, Barac AM, Vekic B, Marinković J. Skin changes in Parkinson’s disease. Med Pregl. 2014;50(3):220–4.
Donadio V, Incensi A, Leta V, et al. Skin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology. 2014;82(15):1362–9.
Li Y, Ge S, Peng C, et al. Skin α-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. Front Aging Neurosci. 2020;12:580641. doi:10.3389/fnagi.2020.580641
